Total Valuation
BeOne Medicines Ltd has a market cap or net worth of $648.46B. The enterprise value is $236.47K.
Market Cap$648.46B
Enterprise Value$236.47K
Share Statistics
BeOne Medicines Ltd has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders―
Owned by Institutions<0.01%
Financial Efficiency
BeOne Medicines Ltd’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 4.76%.
Return on Equity (ROE)0.07
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)4.76%
Return on Capital Employed (ROCE)0.07
Revenue Per Employee445.91K
Profits Per Employee23.95K
Employee Count12,000
Asset Turnover0.65
Inventory Turnover1.30
Valuation Ratios
The current PE Ratio of BeOne Medicines Ltd is 68.3. BeOne Medicines Ltd’s PEG ratio is -0.81.
PE Ratio68.3
PS Ratio6.10
PB Ratio7.49
Price to Fair Value7.49
Price to FCF34.63
Price to Operating Cash Flow27.87
PEG Ratio-0.81
Income Statement
In the last 12 months, BeOne Medicines Ltd had revenue of 5.35B and earned 287.36M in profits. Earnings per share was 0.20.
Revenue5.35B
Gross Profit4.56B
Operating Income447.80M
Pretax Income417.47M
Net Income287.36M
EBITDA589.69M
Earnings Per Share (EPS)0.20
Cash Flow
In the last 12 months, operating cash flow was 1.29B and capital expenditures -191.17M, giving a free cash flow of 1.10B billion.
Operating Cash Flow1.29B
Free Cash Flow1.10B
Free Cash Flow per Share10.00T>
Dividends & Yields
BeOne Medicines Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
BeOne Medicines Ltd upcoming earnings date is Aug 5, 2026, TBA (Confirmed).
Last Earnings DateMay 6, 2026
Next Earnings DateAug 5, 2026
Ex-Dividend Date―
Financial Position
BeOne Medicines Ltd as a current ratio of 3.41, with Debt / Equity ratio of 43.13%
Current Ratio3.41
Quick Ratio3.08
Debt to Market Cap0.06
Net Debt to EBITDA-5.93
Interest Coverage Ratio7.68
Taxes
In the past 12 months, BeOne Medicines Ltd has paid 130.11M in taxes.
Income Tax130.11M
Effective Tax Rate0.31
Enterprise Valuation
BeOne Medicines Ltd EV to EBITDA ratio is 49.45, with an EV/FCF ratio of 30.92.
EV to Sales5.45
EV to EBITDA49.45
EV to Free Cash Flow30.92
EV to Operating Cash Flow25.82
Balance Sheet
BeOne Medicines Ltd has $4.83B in cash and marketable securities with $2.05B in debt, giving a net cash position of $2.78B billion.
Cash & Marketable Securities$4.83B
Total Debt$2.05B
Net Cash$2.78B
Net Cash Per Share$10.00T>
Tangible Book Value Per Share$3.05
Margins
Gross margin is 87.16%, with operating margin of 8.37%, and net profit margin of 5.37%.
Gross Margin87.16%
Operating Margin8.37%
Pretax Margin7.80%
Net Profit Margin5.37%
EBITDA Margin11.02%
EBIT Margin8.37%
Analyst Forecast
The average price target for BeOne Medicines Ltd is $577.21, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$577.21
Price Target Upside― Upside
Analyst ConsensusStrong Buy
Analyst Count15
Revenue Growth Forecast―
EPS Growth Forecast―